Readystate Asset Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190K Sell
13,236
-308,023
-96% -$4.57M 0.01% 754
2025
Q4
$4.83M Buy
321,259
+74,185
+30% +$1.11M 0.2% 89
2025
Q3
$3.56M Buy
247,074
+214,761
+665% +$3.05M 0.15% 109
2025
Q2
$461K Buy
+32,313
New +$462K 0.01% 398
2025
Q1
Sell
-70,623
Closed -$1.02M 613
2024
Q4
$1.02M Buy
+70,623
New +$1.09M 0.03% 394

Other funds holding BMEZ

Readystate Asset Management's BMEZ Position: Q1 2026 in Review

Readystate Asset Management reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 96% in Q1 2026, selling an estimated $4.57M and leaving 13,236 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #754.

Readystate Asset Management first reported a position in BMEZ in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.83M in Q4 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Readystate Asset Management held 13,236 shares of BlackRock Health Sciences Trust II worth $190K as of Q1 2026.
  • Readystate Asset Management sold 308,023 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $4.57M.
  • BlackRock Health Sciences Trust II made up 0.01% of Readystate Asset Management's portfolio in Q1 2026, its #754 holding.
  • Readystate Asset Management first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and has held it in 5 quarters since.
  • Readystate Asset Management's BlackRock Health Sciences Trust II position peaked at $4.83M in Q4 2025.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.